Your search returned 6 results.

Results
	1.	Estimate of the cost of multiple sclerosis in Spain by literature review. [electronic resource] by Fernández, Oscar Calleja-Hernández, Miguel Angel Meca-Lallana, José Oreja-Guevara, Celia Polanco, Ana Pérez-Alcántara, Ferran Producer: 20170822 In: Expert review of pharmacoeconomics & outcomes research vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Would the Use of Edoxaban Be Cost-effective for the Prevention of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation in Spain? [electronic resource] by Lekuona, Iñaki Anguita, Manuel Zamorano, José Luis Rodríguez, José Manuel Barja de Soroa, Paloma Pérez-Alcántara, Ferran Producer: 20191202 In: Revista espanola de cardiologia (English ed.) vol. 72 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	[Cost-effectiveness analysis of universal screening for thyroid disease in pregnant women in Spain]. [electronic resource] by Donnay Candil, Sergio Balsa Barro, José Antonio Álvarez Hernández, Julia Crespo Palomo, Carlos Pérez-Alcántara, Ferrán Polanco Sánchez, Carlos Producer: 20170428 In: Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion vol. 62 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Cost-utility analysis of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in combination with gemcitabine in metastatic pancreatic cancer in Spain: results of the PANCOSTABRAX study. [electronic resource] by Carrato, Alfredo García, Pilar López, Rafael Macarulla, Teresa Rivera, Fernando Sastre, Javier Gostkorzewicz, Joana Benedit, Patricia Pérez-Alcántara, Ferran Producer: 20160329 In: Expert review of pharmacoeconomics & outcomes research vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	The use of cost per life year gained as a measurement of cost-effectiveness in Spain: a systematic review of recent publications. [electronic resource] by Rodríguez Barrios, José Manuel Pérez Alcántara, Ferran Crespo Palomo, Carlos González García, Paloma Antón De Las Heras, Enrique Brosa Riestra, Max Producer: 20130416 In: The European journal of health economics : HEPAC : health economics in prevention and care vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Cost-utility analysis of nanoparticle albumin-bound paclitaxel versus paclitaxel in monotherapy in pretreated metastatic breast cancer in Spain. [electronic resource] by Alba, Emilio Ciruelos, Eva López, Rafael López-Vega, José Manuel Lluch, Ana Martín, Miguel Muñoz, Montserrat Sánchez-Rovira, Pedro Seguí, Miguel Ángel Liria, Marta Rubio Pérez-Alcántara, Ferran Producer: 20140203 In: Expert review of pharmacoeconomics & outcomes research vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)